Loading…

Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma

Background Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro- d -glucose (FDG)-uptake alteration by anti-PD-1 antibody treatment depicts the response in pa...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 2020-05, Vol.122 (11), p.1686-1694
Main Authors: Togo, Maria, Yokobori, Takehiko, Shimizu, Kimihiro, Handa, Tadashi, Kaira, Kyoichi, Sano, Takaaki, Tsukagoshi, Mariko, Higuchi, Tetsuya, Yokoo, Satoshi, Shirabe, Ken, Oyama, Tetsunari
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93
cites cdi_FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93
container_end_page 1694
container_issue 11
container_start_page 1686
container_title British journal of cancer
container_volume 122
creator Togo, Maria
Yokobori, Takehiko
Shimizu, Kimihiro
Handa, Tadashi
Kaira, Kyoichi
Sano, Takaaki
Tsukagoshi, Mariko
Higuchi, Tetsuya
Yokoo, Satoshi
Shirabe, Ken
Oyama, Tetsunari
description Background Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro- d -glucose (FDG)-uptake alteration by anti-PD-1 antibody treatment depicts the response in patients with lung cancer. This study aims to elucidate the correlations between tumour immune status, clinicopathological factors, 18 F-FDG-uptake and cold tumour phenotypes as low PD-L1 expression/low CD8 + tumour-infiltrating lymphocytes (TILs) in OSCC. Methods We performed immunohistochemical analysis of PD-L1, hypoxia-inducible factor 1 A (HIF-1A), glucose transporter type 1 (GLUT1), CD8, E-cadherin and Ki-67 on 59 operable OSCC samples. We assessed the correlations between these factors and preoperative 18 F-FDG-uptake, clinicopathological characteristics and prognosis. Results Low expression of PD-L1 in OSCC correlated with cancer aggressiveness, poor prognosis, high 18 F-FDG-uptake with HIF-1A/GLUT1 and low E-cadherin expression and low CD8. Cold tumour phenotypes as low PD-L1 tumour cells and low stromal CD8 correlated with the poor prognosis, high 18 F-FDG-uptake and E-cadherin suppression. Furthermore, the high level of preoperative 18 F-FDG-uptake in OSCC was an independent predictor of the cold tumour immune status. Conclusions 18 F-FDG-uptake is an independent predictor of cold tumour in OSCC. 18 F-FDG-PET imaging could be a promising diagnostic tool to estimate tumour immune status.
doi_str_mv 10.1038/s41416-020-0820-z
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7250916</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2406924155</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93</originalsourceid><addsrcrecordid>eNp1Ul2LEzEUDaK4dfUH-BbwRZCs-ZhMkhdB2u2uUHAf1ueQZjJtlpmkm2QWuv_H_2nKFEXBl1xy7zmHey4HgPcEXxHM5OfckIa0CFOMsKzP8wuwIJxRRCQVL8ECYywQVhRfgDc5P9SvwlK8BheMUiYVUQvwc-XNLsRcvIVPZpgcjD0kco3Wqxt0d30PS4SH5DpvCyx7B8s0xilBP45TcDAXU6YMO9f74Dq4PZ7nZoB3K7Qh0IQOLlfy09xGPvR-KMkUH3ZwOI6HfbTH4jL0AcYTKz9OpiIztG4YoDXJ-hBH8xa86s2Q3btzvQQ_1tf3y1u0-X7zbfl1gywToiBpTUe2LeedY9bZlvAtbWthxHHZNpJw4aQSsqXSWsww6zvJrDKKsdbyXrFL8GXWPUzb0XXWhbrsoA_JjyYddTRe_z0Jfq938UkLyrEibRX4eBZI8XFyuejR55MXE1y1pevZucBK8KZCP_wDfagnCtWepg1uFW0I5xVFZpRNMefk-t_LEKxPIdBzCHQNgT6FQD9XDp05uWLDzqU_yv8n_QJEI7Vk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2406924155</pqid></control><display><type>article</type><title>Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma</title><source>Open Access: PubMed Central</source><source>Springer Nature</source><creator>Togo, Maria ; Yokobori, Takehiko ; Shimizu, Kimihiro ; Handa, Tadashi ; Kaira, Kyoichi ; Sano, Takaaki ; Tsukagoshi, Mariko ; Higuchi, Tetsuya ; Yokoo, Satoshi ; Shirabe, Ken ; Oyama, Tetsunari</creator><creatorcontrib>Togo, Maria ; Yokobori, Takehiko ; Shimizu, Kimihiro ; Handa, Tadashi ; Kaira, Kyoichi ; Sano, Takaaki ; Tsukagoshi, Mariko ; Higuchi, Tetsuya ; Yokoo, Satoshi ; Shirabe, Ken ; Oyama, Tetsunari</creatorcontrib><description>Background Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro- d -glucose (FDG)-uptake alteration by anti-PD-1 antibody treatment depicts the response in patients with lung cancer. This study aims to elucidate the correlations between tumour immune status, clinicopathological factors, 18 F-FDG-uptake and cold tumour phenotypes as low PD-L1 expression/low CD8 + tumour-infiltrating lymphocytes (TILs) in OSCC. Methods We performed immunohistochemical analysis of PD-L1, hypoxia-inducible factor 1 A (HIF-1A), glucose transporter type 1 (GLUT1), CD8, E-cadherin and Ki-67 on 59 operable OSCC samples. We assessed the correlations between these factors and preoperative 18 F-FDG-uptake, clinicopathological characteristics and prognosis. Results Low expression of PD-L1 in OSCC correlated with cancer aggressiveness, poor prognosis, high 18 F-FDG-uptake with HIF-1A/GLUT1 and low E-cadherin expression and low CD8. Cold tumour phenotypes as low PD-L1 tumour cells and low stromal CD8 correlated with the poor prognosis, high 18 F-FDG-uptake and E-cadherin suppression. Furthermore, the high level of preoperative 18 F-FDG-uptake in OSCC was an independent predictor of the cold tumour immune status. Conclusions 18 F-FDG-uptake is an independent predictor of cold tumour in OSCC. 18 F-FDG-PET imaging could be a promising diagnostic tool to estimate tumour immune status.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/s41416-020-0820-z</identifier><identifier>PMID: 32238919</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/327 ; 631/67/580/1884 ; 692/53/2421 ; Apoptosis ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; CD8 antigen ; Cold ; Drug Resistance ; E-cadherin ; Epidemiology ; Glucose transporter ; Hypoxia-inducible factor 1 ; Hypoxia-inducible factor 1a ; Hypoxia-inducible factors ; Immune checkpoint ; Immune status ; Lung cancer ; Lymphocytes ; Medical diagnosis ; Molecular Medicine ; Oncology ; Oral cancer ; Oral squamous cell carcinoma ; PD-1 protein ; PD-L1 protein ; Phenotypes ; Positron emission tomography ; Prognosis ; Squamous cell carcinoma ; Tumors</subject><ispartof>British journal of cancer, 2020-05, Vol.122 (11), p.1686-1694</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93</citedby><cites>FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250916/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250916/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Togo, Maria</creatorcontrib><creatorcontrib>Yokobori, Takehiko</creatorcontrib><creatorcontrib>Shimizu, Kimihiro</creatorcontrib><creatorcontrib>Handa, Tadashi</creatorcontrib><creatorcontrib>Kaira, Kyoichi</creatorcontrib><creatorcontrib>Sano, Takaaki</creatorcontrib><creatorcontrib>Tsukagoshi, Mariko</creatorcontrib><creatorcontrib>Higuchi, Tetsuya</creatorcontrib><creatorcontrib>Yokoo, Satoshi</creatorcontrib><creatorcontrib>Shirabe, Ken</creatorcontrib><creatorcontrib>Oyama, Tetsunari</creatorcontrib><title>Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><description>Background Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro- d -glucose (FDG)-uptake alteration by anti-PD-1 antibody treatment depicts the response in patients with lung cancer. This study aims to elucidate the correlations between tumour immune status, clinicopathological factors, 18 F-FDG-uptake and cold tumour phenotypes as low PD-L1 expression/low CD8 + tumour-infiltrating lymphocytes (TILs) in OSCC. Methods We performed immunohistochemical analysis of PD-L1, hypoxia-inducible factor 1 A (HIF-1A), glucose transporter type 1 (GLUT1), CD8, E-cadherin and Ki-67 on 59 operable OSCC samples. We assessed the correlations between these factors and preoperative 18 F-FDG-uptake, clinicopathological characteristics and prognosis. Results Low expression of PD-L1 in OSCC correlated with cancer aggressiveness, poor prognosis, high 18 F-FDG-uptake with HIF-1A/GLUT1 and low E-cadherin expression and low CD8. Cold tumour phenotypes as low PD-L1 tumour cells and low stromal CD8 correlated with the poor prognosis, high 18 F-FDG-uptake and E-cadherin suppression. Furthermore, the high level of preoperative 18 F-FDG-uptake in OSCC was an independent predictor of the cold tumour immune status. Conclusions 18 F-FDG-uptake is an independent predictor of cold tumour in OSCC. 18 F-FDG-PET imaging could be a promising diagnostic tool to estimate tumour immune status.</description><subject>631/67/327</subject><subject>631/67/580/1884</subject><subject>692/53/2421</subject><subject>Apoptosis</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>CD8 antigen</subject><subject>Cold</subject><subject>Drug Resistance</subject><subject>E-cadherin</subject><subject>Epidemiology</subject><subject>Glucose transporter</subject><subject>Hypoxia-inducible factor 1</subject><subject>Hypoxia-inducible factor 1a</subject><subject>Hypoxia-inducible factors</subject><subject>Immune checkpoint</subject><subject>Immune status</subject><subject>Lung cancer</subject><subject>Lymphocytes</subject><subject>Medical diagnosis</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Oral cancer</subject><subject>Oral squamous cell carcinoma</subject><subject>PD-1 protein</subject><subject>PD-L1 protein</subject><subject>Phenotypes</subject><subject>Positron emission tomography</subject><subject>Prognosis</subject><subject>Squamous cell carcinoma</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1Ul2LEzEUDaK4dfUH-BbwRZCs-ZhMkhdB2u2uUHAf1ueQZjJtlpmkm2QWuv_H_2nKFEXBl1xy7zmHey4HgPcEXxHM5OfckIa0CFOMsKzP8wuwIJxRRCQVL8ECYywQVhRfgDc5P9SvwlK8BheMUiYVUQvwc-XNLsRcvIVPZpgcjD0kco3Wqxt0d30PS4SH5DpvCyx7B8s0xilBP45TcDAXU6YMO9f74Dq4PZ7nZoB3K7Qh0IQOLlfy09xGPvR-KMkUH3ZwOI6HfbTH4jL0AcYTKz9OpiIztG4YoDXJ-hBH8xa86s2Q3btzvQQ_1tf3y1u0-X7zbfl1gywToiBpTUe2LeedY9bZlvAtbWthxHHZNpJw4aQSsqXSWsww6zvJrDKKsdbyXrFL8GXWPUzb0XXWhbrsoA_JjyYddTRe_z0Jfq938UkLyrEibRX4eBZI8XFyuejR55MXE1y1pevZucBK8KZCP_wDfagnCtWepg1uFW0I5xVFZpRNMefk-t_LEKxPIdBzCHQNgT6FQD9XDp05uWLDzqU_yv8n_QJEI7Vk</recordid><startdate>20200526</startdate><enddate>20200526</enddate><creator>Togo, Maria</creator><creator>Yokobori, Takehiko</creator><creator>Shimizu, Kimihiro</creator><creator>Handa, Tadashi</creator><creator>Kaira, Kyoichi</creator><creator>Sano, Takaaki</creator><creator>Tsukagoshi, Mariko</creator><creator>Higuchi, Tetsuya</creator><creator>Yokoo, Satoshi</creator><creator>Shirabe, Ken</creator><creator>Oyama, Tetsunari</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200526</creationdate><title>Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma</title><author>Togo, Maria ; Yokobori, Takehiko ; Shimizu, Kimihiro ; Handa, Tadashi ; Kaira, Kyoichi ; Sano, Takaaki ; Tsukagoshi, Mariko ; Higuchi, Tetsuya ; Yokoo, Satoshi ; Shirabe, Ken ; Oyama, Tetsunari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/67/327</topic><topic>631/67/580/1884</topic><topic>692/53/2421</topic><topic>Apoptosis</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>CD8 antigen</topic><topic>Cold</topic><topic>Drug Resistance</topic><topic>E-cadherin</topic><topic>Epidemiology</topic><topic>Glucose transporter</topic><topic>Hypoxia-inducible factor 1</topic><topic>Hypoxia-inducible factor 1a</topic><topic>Hypoxia-inducible factors</topic><topic>Immune checkpoint</topic><topic>Immune status</topic><topic>Lung cancer</topic><topic>Lymphocytes</topic><topic>Medical diagnosis</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Oral cancer</topic><topic>Oral squamous cell carcinoma</topic><topic>PD-1 protein</topic><topic>PD-L1 protein</topic><topic>Phenotypes</topic><topic>Positron emission tomography</topic><topic>Prognosis</topic><topic>Squamous cell carcinoma</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Togo, Maria</creatorcontrib><creatorcontrib>Yokobori, Takehiko</creatorcontrib><creatorcontrib>Shimizu, Kimihiro</creatorcontrib><creatorcontrib>Handa, Tadashi</creatorcontrib><creatorcontrib>Kaira, Kyoichi</creatorcontrib><creatorcontrib>Sano, Takaaki</creatorcontrib><creatorcontrib>Tsukagoshi, Mariko</creatorcontrib><creatorcontrib>Higuchi, Tetsuya</creatorcontrib><creatorcontrib>Yokoo, Satoshi</creatorcontrib><creatorcontrib>Shirabe, Ken</creatorcontrib><creatorcontrib>Oyama, Tetsunari</creatorcontrib><collection>SpringerOpen</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Togo, Maria</au><au>Yokobori, Takehiko</au><au>Shimizu, Kimihiro</au><au>Handa, Tadashi</au><au>Kaira, Kyoichi</au><au>Sano, Takaaki</au><au>Tsukagoshi, Mariko</au><au>Higuchi, Tetsuya</au><au>Yokoo, Satoshi</au><au>Shirabe, Ken</au><au>Oyama, Tetsunari</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><date>2020-05-26</date><risdate>2020</risdate><volume>122</volume><issue>11</issue><spage>1686</spage><epage>1694</epage><pages>1686-1694</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><abstract>Background Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro- d -glucose (FDG)-uptake alteration by anti-PD-1 antibody treatment depicts the response in patients with lung cancer. This study aims to elucidate the correlations between tumour immune status, clinicopathological factors, 18 F-FDG-uptake and cold tumour phenotypes as low PD-L1 expression/low CD8 + tumour-infiltrating lymphocytes (TILs) in OSCC. Methods We performed immunohistochemical analysis of PD-L1, hypoxia-inducible factor 1 A (HIF-1A), glucose transporter type 1 (GLUT1), CD8, E-cadherin and Ki-67 on 59 operable OSCC samples. We assessed the correlations between these factors and preoperative 18 F-FDG-uptake, clinicopathological characteristics and prognosis. Results Low expression of PD-L1 in OSCC correlated with cancer aggressiveness, poor prognosis, high 18 F-FDG-uptake with HIF-1A/GLUT1 and low E-cadherin expression and low CD8. Cold tumour phenotypes as low PD-L1 tumour cells and low stromal CD8 correlated with the poor prognosis, high 18 F-FDG-uptake and E-cadherin suppression. Furthermore, the high level of preoperative 18 F-FDG-uptake in OSCC was an independent predictor of the cold tumour immune status. Conclusions 18 F-FDG-uptake is an independent predictor of cold tumour in OSCC. 18 F-FDG-PET imaging could be a promising diagnostic tool to estimate tumour immune status.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32238919</pmid><doi>10.1038/s41416-020-0820-z</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 2020-05, Vol.122 (11), p.1686-1694
issn 0007-0920
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7250916
source Open Access: PubMed Central; Springer Nature
subjects 631/67/327
631/67/580/1884
692/53/2421
Apoptosis
Biomedical and Life Sciences
Biomedicine
Cancer Research
CD8 antigen
Cold
Drug Resistance
E-cadherin
Epidemiology
Glucose transporter
Hypoxia-inducible factor 1
Hypoxia-inducible factor 1a
Hypoxia-inducible factors
Immune checkpoint
Immune status
Lung cancer
Lymphocytes
Medical diagnosis
Molecular Medicine
Oncology
Oral cancer
Oral squamous cell carcinoma
PD-1 protein
PD-L1 protein
Phenotypes
Positron emission tomography
Prognosis
Squamous cell carcinoma
Tumors
title Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A57%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20value%20of%2018F-FDG-PET%20to%20predict%20the%20tumour%20immune%20status%20defined%20by%20tumoural%20PD-L1%20and%20CD8+tumour-infiltrating%20lymphocytes%20in%20oral%20squamous%20cell%20carcinoma&rft.jtitle=British%20journal%20of%20cancer&rft.au=Togo,%20Maria&rft.date=2020-05-26&rft.volume=122&rft.issue=11&rft.spage=1686&rft.epage=1694&rft.pages=1686-1694&rft.issn=0007-0920&rft.eissn=1532-1827&rft_id=info:doi/10.1038/s41416-020-0820-z&rft_dat=%3Cproquest_pubme%3E2406924155%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c377t-8cad1b655de3cec615b26c6131e58648157e8978628cc0303fd83c9a9336c5f93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2406924155&rft_id=info:pmid/32238919&rfr_iscdi=true